Announcements Trials

Browse Landscape

Phase

Phase 2/3 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Neoplasm Metastasis 2 Melanoma 2 Breast Neoplasms 2 Brain Neoplasms 2 Thyroid Cancer, Papillary 1 Solid Tumors 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rare Tumour 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Noonan Syndrome 6 1 Neuroendocrine Tumors 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Lymphoma, Large-Cell, Anaplastic 1 Locally Advanced Thyroid Gland Carcinoma 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Advanced Unresectable or Metastatic Solid Malignancy 1

Interventions

Cyclophosphamide 41 fludarabine 35 Tacrolimus 28 Mycophenolic Acid 27 Whole-Body Irradiation 25 Busulfan 24 fludarabine phosphate 21 Melphalan 19 thymoglobulin 16 Antilymphocyte Serum 16 Methotrexate 13 Thiotepa 12 Stem Cell Transplantation 9 Rituximab 9 Granulocyte Colony-Stimulating Factor 9 Filgrastim 8 Cyclosporine 8 trametinib 7 Sirolimus 7 Nivolumab 5 ruxolitinib 4 merphos 4 Peripheral Blood Stem Cell Transplantation 4 Cytarabine 4 Cord Blood Stem Cell Transplantation 4 Bendamustine Hydrochloride 4 tocilizumab 3 itacitinib 3 fedratinib 3 dabrafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hematologic Neoplasms × entrectinib × Clear all

NCT05159245 2024-07-15

FINPROVE

Helsinki University Central Hospital

Phase 2 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡